Drug recall · February 16, 2022
DBI Magnums Tablet recall
Why: CGMP Deviations
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
DBI Magnums Tablet (Caffeine 200 mg) 100 and 500 count & 3 and 36 count packets & Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-941-00
- Lots / codes
Product Codes: M941L M940LA Bulk Lots: 19C065, 19F081, 19H083, 17D088
- Quantity
- 8,727,657 tablets
- Company
- ULTRAtab Laboratories, Inc., Highland, NY
- Distribution
- Bulk product was distributed to 3 distributors who may have distributed finished product.
- Initiated
- January 26, 2022 · Voluntary: Firm initiated
- Classified
- February 9, 2022
- Reported
- February 16, 2022
- Ended
- January 7, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Caffeine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.